Literature DB >> 28839587

Development of an integrated pancreatic disease service.

James A Jupp1, Colin D Johnson2, Fanny W Shek3, David R Fine3.   

Abstract

An integrated pancreatic disease unit needs to deliver high-quality care both to patients with malignant and non-malignant pancreatic disease. The regionalisation of pancreatic cancer services which followed the publication of policy frameworks by the Department of Health and NHS executive led to the development of disease-site-specialised high-volume multidisciplinary teams. As the majority of patients with pancreatic cancer are not suitable for surgery, partner hospitals within a region need to provide access to a wide range of non-surgical treatment. The implementation of such working may require pooling of local resources to create networks of equivalence to tertiary centres. The provision of care to non-malignant pancreatic disease can benefit from this type of working and services can be modelled on, and integrate with, cancer services. One way of achieving this is to establish working groups based upon diseases rather than traditional departments, which can deliver standardised and optimal care with a patient-centred approach. However, this poses a number of potential problems. This review examines how an integrated pancreatic unit may be developed in district general and larger hospitals, and also describes our experience in developing such a unit.

Entities:  

Year:  2011        PMID: 28839587      PMCID: PMC5517202          DOI: 10.1136/fg.2009.000562

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  16 in total

Review 1.  Resection for pancreatic cancer in the new millennium.

Authors:  Ake Andrén-Sandberg; John P Neoptolemos
Journal:  Pancreatology       Date:  2002       Impact factor: 3.996

Review 2.  Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

3.  Epidemiology of pancreatic diseases in Lüneburg County. A study in a defined german population.

Authors:  P G Lankisch; C Assmus; P Maisonneuve; A B Lowenfels
Journal:  Pancreatology       Date:  2002       Impact factor: 3.996

4.  Justifying the expense of the cancer Clinical Nurse Specialist.

Authors:  C A Pollard; G Garcea; C J Pattenden; R Curran; C P Neal; D P Berry; A R Dennison
Journal:  Eur J Cancer Care (Engl)       Date:  2009-08-20       Impact factor: 2.520

5.  Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group.

Authors:  J P Neoptolemos; R C Russell; S Bramhall; B Theis
Journal:  Br J Surg       Date:  1997-10       Impact factor: 6.939

6.  National statistics for diet, alcohol consumption, and chronic pancreatitis in England and Wales, 1960-88.

Authors:  C D Johnson; S Hosking
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

7.  Influence of specialization on the management and outcome of patients with pancreatic cancer.

Authors:  M O Bachmann; D Alderson; T J Peters; C Bedford; D Edwards; S Wotton; I M Harvey
Journal:  Br J Surg       Date:  2003-02       Impact factor: 6.939

8.  Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer.

Authors:  Timothy M Pawlik; Daniel Laheru; Ralph H Hruban; Joann Coleman; Christopher L Wolfgang; Kurt Campbell; Syed Ali; Elliot K Fishman; Richard D Schulick; Joseph M Herman
Journal:  Ann Surg Oncol       Date:  2008-05-07       Impact factor: 5.344

9.  Incidence and case fatality for acute pancreatitis in England: geographical variation, social deprivation, alcohol consumption and aetiology--a record linkage study.

Authors:  S E Roberts; J G Williams; D Meddings; M J Goldacre
Journal:  Aliment Pharmacol Ther       Date:  2008-07-18       Impact factor: 8.171

10.  Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000.

Authors:  D Fitzsimmons; C Osmond; S George; C D Johnson
Journal:  Br J Surg       Date:  2007-09       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.